Mehmet Sen

Leeds, ENG, GB 
Leeds, ENG, GB 

Overview

Mehmet Sen practices practicing medicine in Leeds, United Kingdom.

His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Cerebral Hypoxia, Human Papillomavirus Infection, Throat Cancer, and Gastrostomy.

He is actively involved in clinical research, co-authoring 23 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Leeds, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase III Randomised Controlled Trial Comparing Alternative Regimens for Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer
Phase III Randomised Controlled Trial Comparing Alternative Regimens for Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 07, 2026
Intervention Type: Drug, Procedure
Study Drugs: Cisplatin, Durvalumab
Study Phase: Phase 3
A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)
A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)
Enrollment Status: Completed
Publish Date: October 19, 2021
Intervention Type: Drug, Radiation
Study Phase: Phase 3
Determination of Epidermal Growth Factor Receptor-inhibitor (Cetuximab) Versus Standard Chemotherapy (Cisplatin) Early And Late Toxicity Events in Human Papillomavirus-positive Oropharyngeal Squamous Cell Carcinoma
Determination of Epidermal Growth Factor Receptor-inhibitor (Cetuximab) Versus Standard Chemotherapy (Cisplatin) Early And Late Toxicity Events in Human Papillomavirus-positive Oropharyngeal Squamous Cell Carcinoma
Enrollment Status: Unknown
Publish Date: May 08, 2017
Intervention Type: Drug
Study Drugs: Cisplatin, Cetuximab
Study Phase: Phase 3
View 2 Less Clinical Trials

23 Total Publications

Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD).
Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD).
Journal: International journal of radiation oncology, biology, physics
Published: October 30, 2023

Frequently Asked Questions about Mehmet Sen

Is Mehmet Sen a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Mehmet Sen is classified as an Experienced expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mehmet Sen participate in research or clinical trials?

Yes. Mehmet Sen has published 23 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Mehmet Sen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sen's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile